GlobeNewsWire
22 Jul 2026, 23:33 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
A securities fraud class action lawsuit has been filed against ADMA Biologics, Inc. (NASDAQ: ADMA). — Lawsuits alleging fraud typically trigger immediate investor skepticism and downward pressure on the stock price.
-0.60The lawsuit alleges ADMA misrepresented its financial condition, revenue recognition, inventory distribution, and business practices to artificially inflate stock value. — Claims targeting the integrity of financial reporting and revenue recognition are high-signal risks that can lead to accounting restatements.
-0.50Corrective disclosure events have already occurred, resulting in a loss of substantial shareholder value. — This indicates that the market has already begun pricing in the negative news, reducing the potential for a new, sudden shock.
-0.30Which stocks this story touches
Continue reading
6 related stories
Search tags
The company is facing a securities fraud class action lawsuit alleging misrepresentations of financial condition and revenue recognition.
Investors are urged to contact legal counsel following a stock plunge due to allegedly misleading financial statements.
Investors are urged to contact legal counsel following a stock plunge due to allegedly misleading financial statements.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
GlobeNewsWire
6h ago
